查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1621890

狗驱虫剂市场机会、成长驱动因素、产业趋势分析与预测 2024 - 2032 年

Dog Dewormers Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 100 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年，全球狗用驱虫剂市场价值为14亿美元，预计2024年至2032年复合年增长率为9.5%。这一趋势的主要因素市场成长。宠物拥有量的上升趋势极大地影响了市场的扩张。生活方式的改变和城市化正在导致越来越多的人透过宠物（尤其是狗）寻求陪伴。报告显示，相当大比例的美国家庭拥有宠物，反映出更广泛的全球趋势，即兽医护理和宠物产品支出持续成长。

随着宠物主人优先考虑采取预防措施来维持宠物健康，对有效驱虫解决方案的需求预计将会成长。狗驱虫剂市场按产品类型分为外用溶液、片剂和咀嚼片以及注射剂。片剂和咀嚼片细分市场成为最高的收入来源，到2023 年将带来约7.686 亿美元的收入。更容易被狗摄入，并且经常被接受无需大惊小怪。狗驱虫剂的通路包括兽医诊所、零售药局、线上平台和宠物商店。

兽医诊所部门产生的收入最多，2023 年总计约为 5.602 亿美元。这种专业指导增强了宠物主人对他们选择的产品的信心，增强了他们对安全性和功效的认知。在北美，狗驱虫剂市场到 2023 年将产生 5.133 亿美元的收入，预计在预测期内复合年增长率为 9.1%。该地区，尤其是美国和加拿大，是全球宠物拥有率最高的地区之一。

市场范围
开始年份 2023年
预测年份 2024-2032
起始值 14亿美元
预测值 31亿美元
复合年增长率 9.5%

养宠物家庭数量的增加刺激了对狗驱虫剂的需求。此外，人们也越来越意识到宠物预防保健的重要性。随着宠物主人对寄生虫感染危险的了解越来越多，他们更倾向于投资定期驱虫治疗，以确保他们的狗保持健康且没有寄生虫

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 增加宠物拥有量
      • 驱虫剂配方的进步
      • 更重视人畜共通传染病
      • 人们对宠物健康的认知不断增强
    • 产业陷阱与挑战
      • 监管挑战
  • 成长潜力分析
  • 监管环境
  • 技术景观
  • 未来市场趋势
  • 差距分析
  • 波特的分析
  • PESTEL分析

第 4 章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章：市场估计与预测：按产品类型，2021 - 2032 年

  • 主要趋势
  • 片剂和咀嚼片
  • 局部解决方案
  • 注射

第 6 章：市场估计与预测：按配销通路，2021 - 2032 年

  • 主要趋势
  • 兽医诊所
  • 零售药局
  • 线上平台
  • 宠物店

第 7 章：市场估计与预测：按地区划分，2021 - 2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿联酋
    • 中东和非洲其他地区

第 8 章：公司简介

  • Bayer AG
  • Beaphar
  • Bimeda, Inc.
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Durvet Animal Health Products
  • Elanco Animal Health Incorporated
  • Jurox Pty Limited
  • Merck & Co., Inc.
  • Ourofino Animal Health
  • PetIQ, LLC.
  • Sava Healthcare Limited
  • Vetoquinol
  • Virbac SA
  • Zoetis Inc.
简介目录
Product Code: 11674

The Global Dog Dewormers Market was valued at USD 1.4 billion in 2023 and is projected to expand at a 9.5% CAGR from 2024 to 2032. The surge in pet ownership, coupled with an increasing emphasis on preventing zoonotic diseases, is a major factor driving this market growth. The rising trend of pet ownership significantly influences market expansion. Changing lifestyles and urbanization are leading more individuals to seek companionship through pets, particularly dogs. Reports indicate that a substantial percentage of households in the U.S. own pets, reflecting a broader global trend where spending on veterinary care and pet products continues to rise.

As pet owners prioritize preventive measures to maintain pet health, the demand for effective deworming solutions is expected to grow. The dog dewormers market is categorized by product type into topical solutions, tablets & chewable treats, and injections. The tablets and chewable treats segment emerged as the highest revenue generator, bringing in approximately USD 768.6 million in 2023. This segment's popularity stems from its convenience and high compliance rates among pet owners, as flavored chewables are easier for dogs to ingest and are often accepted without fuss. Distribution channels for dog dewormers include veterinary clinics, retail pharmacies, online platforms, and pet stores.

The veterinary clinics segment generated the most revenue, totaling around USD 560.2 million in 2023. The expertise provided by veterinarians ensures that dewormers are tailored to meet each dog's specific needs. This professional guidance boosts pet owners' confidence in the products they choose, enhancing their perception of safety and efficacy. In North America, the dog dewormers market generated USD 513.3 million in revenue in 2023 and is anticipated to grow at a CAGR of 9.1% over the forecast period. This region, particularly the United States and Canada, boasts one of the highest pet ownership rates globally.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$1.4 Billion
Forecast Value$3.1 Billion
CAGR9.5%

The increasing number of pet-owning households fuels the demand for dog dewormers. Furthermore, there is a growing awareness of the significance of preventive healthcare for pets. As pet owners become more educated about the dangers of parasitic infections, they are more inclined to invest in regular deworming treatments to ensure their dogs remain healthy and parasite-free

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increased pet ownership
      • 3.2.1.2 Advancements in dewormer formulations
      • 3.2.1.3 Increased focus on zoonotic diseases
      • 3.2.1.4 Growing awareness about pet health
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Regulatory challenges
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Future market trends
  • 3.7 Gap analysis
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Tablets and chewable treats
  • 5.3 Topical solutions
  • 5.4 Injections

Chapter 6 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Veterinary clinics
  • 6.3 Retail pharmacies
  • 6.4 Online platforms
  • 6.5 Pet stores

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Netherlands
    • 7.3.7 Rest of the Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
    • 7.4.6 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Rest of Latin America
  • 7.6 Middle East and Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 South Africa
    • 7.6.3 UAE
    • 7.6.4 Rest of Middle East and Africa

Chapter 8 Company Profiles

  • 8.1 Bayer AG
  • 8.2 Beaphar
  • 8.3 Bimeda, Inc.
  • 8.4 Boehringer Ingelheim International GmbH
  • 8.5 Ceva Sante Animale
  • 8.6 Durvet Animal Health Products
  • 8.7 Elanco Animal Health Incorporated
  • 8.8 Jurox Pty Limited
  • 8.9 Merck & Co., Inc.
  • 8.10 Ourofino Animal Health
  • 8.11 PetIQ, LLC.
  • 8.12 Sava Healthcare Limited
  • 8.13 Vetoquinol
  • 8.14 Virbac SA
  • 8.15 Zoetis Inc.